| |
| |
|
| Insider
Information: |
Valliant John |
| Relationship: |
Chief Executive Office... |
| City: |
Hamilton |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
318,147 |
|
|
Indirect Shares
|
531,934 |
|
|
| Direct
Value |
$6,833,798 |
|
|
|
Indirect Value
|
$11,425,942 |
|
|
| Total
Shares |
850,081 |
|
|
| Total
Value |
$18,259,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fusion Pharmaceuticals Inc. |
FUSN |
Chief Executive Office... |
2022-04-27 |
318,147 |
2020-06-25 |
531,934 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-27 |
4 |
AS |
$6.03 |
$27,201 |
D/D |
(4,511) |
318,147 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-26 |
4 |
AS |
$6.07 |
$13,032 |
D/D |
(2,147) |
322,658 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-25 |
4 |
AS |
$6.03 |
$12,277 |
D/D |
(2,036) |
324,805 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-21 |
4 |
AS |
$6.01 |
$5,541 |
D/D |
(922) |
326,841 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-20 |
4 |
AS |
$6.02 |
$2,209 |
D/D |
(367) |
327,763 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-13 |
4 |
AS |
$6.41 |
$76,882 |
D/D |
(11,994) |
328,130 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-12 |
4 |
AS |
$7.10 |
$129,611 |
D/D |
(18,255) |
340,124 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-11 |
4 |
AS |
$7.37 |
$19,162 |
D/D |
(2,600) |
358,379 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-08 |
4 |
AS |
$7.52 |
$6,212 |
D/D |
(826) |
360,979 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-07 |
4 |
AS |
$7.56 |
$9,488 |
D/D |
(1,255) |
361,805 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-06 |
4 |
AS |
$7.58 |
$758 |
D/D |
(100) |
363,060 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-05 |
4 |
AS |
$7.67 |
$16,107 |
D/D |
(2,100) |
363,160 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-04 |
4 |
AS |
$7.81 |
$5,467 |
D/D |
(700) |
365,260 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-04-01 |
4 |
AS |
$7.75 |
$7,750 |
D/D |
(1,000) |
365,960 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-30 |
4 |
AS |
$7.52 |
$2,256 |
D/D |
(300) |
366,960 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-29 |
4 |
AS |
$7.52 |
$1,504 |
D/D |
(200) |
367,260 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-28 |
4 |
AS |
$7.55 |
$72,480 |
D/D |
(9,600) |
367,460 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-25 |
4 |
AS |
$7.42 |
$3,710 |
D/D |
(500) |
377,060 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-23 |
4 |
AS |
$7.50 |
$750 |
D/D |
(100) |
378,260 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-22 |
4 |
AS |
$7.53 |
$30,120 |
D/D |
(4,000) |
378,360 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-21 |
4 |
AS |
$7.47 |
$11,205 |
D/D |
(1,500) |
382,360 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-21 |
4 |
AS |
$7.46 |
$5,222 |
D/D |
(700) |
377,560 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-18 |
4 |
AS |
$7.61 |
$9,162 |
D/D |
(1,204) |
383,860 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-17 |
4 |
AS |
$7.51 |
$6,759 |
D/D |
(900) |
385,064 |
0 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-03-16 |
4 |
AS |
$6.99 |
$699 |
D/D |
(100) |
385,964 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
